ReviewCurrent cardiology reports2025
Endovascular Treatment for Aortic Diseases: Intercontinental Disparities.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review explores the intercontinental disparities in endovascular treatment for aortic diseases, focusing on North America, Europe, Africa and Asia with special focus Southeast Asia(India). It highlights device availability, cost, accessibility, patient outcomes, and the necessity for improved healthcare equity. RECENT
findingsThe management of aortic diseases such as aneurysms and dissections has improved with endovascular techniques like thoracic endovascular aortic repair and fenestrated-branched repair. These minimally invasive procedures offer benefits over traditional surgery, including lower morbidity and mortality rates, reduced hospital stays, faster recovery times, and generally higher patient satisfaction. However, their adoption varies across continents due to differences in healthcare infrastructure, economic resources, regulatory environments, and physician expertise. By examining the current landscape of endovascular aortic treatment globally, we can better understand the challenges and opportunities for enhancing aortic care and ensuring equitable access for all patients, regardless of their geographic location and socioeconomic status.
Indexed as
Identifiers
40691402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.